Citrollenol Abrogates Neuroinflammatory Pathway Regulated via Induction of NF-kB in AlCl3 Induced Alzheimer’s Disease – Molecular Approach
Xiaoli Zhou1, Hesham S. Almoallim2, Balasubramani Ravindran3, Rui Qin4★★ Corresponding author
- 1Department of Neurology, 3201 Hospital, Hanzhong, CHINA.
- 2Department of Oral and Maxillofacial Surgery, College of Dentistry, King Saud University, Riyadh, SAUDI ARABIA.
- 3Department of Environmental Energy and Engineering, Kyonggi University, Yeongtong-Gu, Suwon, Gyeonggi, REPUBLIC OF KOREA.
- 4Department of Rehabilitation, Hanzhong Traditional Chinese Medicine Hospital, Hanzhong, CHINA.
CORRESPONDENCE
Rui Qin
Department of Rehabilitation, Hanzhong Traditional Chinese Medicine Hospital, Hanzhong-723000, CHINA.
Received: 31-01-2023; Revised: 23-03-2023; Accepted: 01-05-2023.
Volume 57, Issue 4 · pp. 1053–1060 · PUBLISHED 2023 · DOI:
ABSTRACT
Background: Alzheimer's Disease (AD), a neurodegenerative disorder characterized by dementia, is linked to ROS-induced stress, neuroinflammation, and gut microbiota imbalance. Objectives: The antioxidant and anti-inflammatory properties of citrollenol have already been reported. The current research was aimed at discovering the salutary properties of citrollenol against Aluminum Chloride (AlCl3)-induced AD in rats. Materials and Methods: The AlCl3 was used to induce the AD in rats and then treated with citrollenol (25 and 50 mg/kg/bw). The behavioral tests were conducted on both control and treated rats. The levels of antioxidants and acetylcholine esterase were assessed using kits. The histopathological and immunohistochemical analyses were performed on the brain tissues. Results: The findings revealed that the AlCl3-induced group had a loss of memory capability as well as an increase in the production of proinflammatory and neurodegenerative disorder-related AD proteins; otherwise, these characteristics were contrasted in the citrollenol-treated groups. Citrollenol-induced rats showed higher production of antioxidant enzyme levels and lower MDA status. Additionally, citrollenol abrogates proinflammatory mediator expression by suppressing NF-κB signaling and regulating microglial activation. Conclusion: Citrollenol can drawnback the AD brain tissue appearance of pathology study by leaking dysfunction in memory, learning capability, production of higher antioxidant enzymes levels, changing immunomodulatory cytokines levels in AlCl3 induced rats, exhibiting that AD pathogenesis may be represented by treatment with citrollenol via the neurodegenerative disorder causes from AD.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Zhou, X., Almoallim, H. S., Ravindran, B., & Qin, R. (2023). Citrollenol Abrogates Neuroinflammatory Pathway Regulated via Induction of NF-kB in AlCl3 Induced Alzheimer’s Disease – Molecular Approach. Indian Journal of Pharmaceutical Education and Research, 57(4), 1053–1060.